Company / Current Liabilities
Compass Therapeutics, Inc. Current Liabilities History
FY2018-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$8.9M
FY2024
5-year range
$7.8M / $16.2M
FY2020-FY2024
Trend
+13.8%
vs FY2023
Sector context
#208 of 213
Health Care
What the data says
Among 213 Health Care companies, Compass Therapeutics, Inc. is in the top 2% for current liabilities. Improved from $16M to $9M over the past 2 years.
Based on SEC 10-K filings.
$9M in FY2024 with a 5-year CAGR of -2.0%.
Improved from $16M to $9M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- -5.8%
- 5-Year CAGR
- -2.0%
- 10-Year CAGR
- -
Sector benchmark
Top 2% in Health CareTop 2% of 213This company $8.9M Sector average $1.6B
▼
-99.4% below sector average
Key checks
Key Insights
- 5-year CAGR of -2.0%, indicating a declining trend.
- In FY2024, current liabilities increased 13.8% year-over-year.
- Ranks #208 out of 213 companies in the Health Care sector.
- Peak current liabilities was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $8.9M | +13.8% |
| FY2023 | $7.8M | -51.8% |
| FY2022 | $16.2M | +52.1% |
| FY2021 | $10.6M | +5.3% |
| FY2020 | $10.1M | +2.8% |
| FY2019 | $9.8M | +28303.3% |
| FY2018 | $34.6K | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026